What the analyst said
Barclays analyst Jiong Shao lowered the price target on XPeng (NYSE: XPEV) to $12 (from $14) while maintaining an Underweight rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
XPEV trades at $9.97. The 7 analysts who set a target in the last 3 months range from $10 to $20, with a median of $15. This $12 target is 20% below the median.
12-month window: day 0 of 365, closes on November 18, 2027.
Track record
This callOpen: a 12-month target, scored on November 18, 2027, a year after the note.
Firm track recordBarclays: 84% of its 43 targets at least a year old were reached within 12 months (#5 of 29 firms). Accuracy ranking →
Barclays on XPeng
Barclays price targets on XPeng
4 calls from February 19, 2026 to November 18, 2026. The target went from $17 to $12 (−29%). The rating stayed Sell.
- November 18, 2026 This noteTarget cut from $14 (−14%)Sell$12
- August 25, 2026Target cut from $16 (−13%)Sell$14
- March 23, 2026Target cut from $17 (−6%)Sell$16
- February 19, 2026Earliest call shownSell$17





